| Cat. No. | 
                Product Name | 
                
                Information | 
            
            
                
            	| PC-21571 | 
                
                	
                		 TY-2136 
                       
                  	
                    ROS1/TRK/ALK inhibitor 
                 | 
                
                TY-2136 is a next generation ROS1/TRK/ALK inhibitor with IC50 of 1.6 nM and 460.1 nM for ROS1 G2032R and TRKA G595R, respectively, inhibits  ROS1/TRK/ALK mutations and overcomes drug resistance due to acquired solvent-front mutations. | 
            
            
                
            	| PC-20952 | 
                
                	
                		 Unecritinib 
                       
                  	
                    ALK/ROS1 inhibitor 
                 | 
                
                Unecritinib (TQ-B3101) is a novel kinase inhibitor targeting receptor tyrosine kinases including ALK, ROS1 and MET, inhibits AKT phosphorylation and downstream signaling molecules ERK1/2, has IC50 of 142.7 nM for wildtype ROS1. | 
            
            
                
            	| PC-49635 | 
                
                	
                		 NVL-520 
                       
                  	
                    ROS1 inhibitor 
                 | 
                
                Zidesamtinib (NVL-520, NVL520) is a potent, selective, TRK-sparing, and brain-penetrant inhibitor of ROS1 fusions and secondary resistance mutations with IC50 of 0.5-3.5 nM, and 12 nM for ROS1 WT. | 
            
            
                
            	| PC-73061 | 
                
                	
                		 Taletrectinib 
                       
                  	
                    ROS1/NTRK inhibitor 
                 | 
                
                DS-6051b (Taletrectinib, DS 6051b) is a new-generation selective ROS1/NTRK inhibitor, potently inhibits recombinant ROS1, NTRK1, and NTRK3 in sub-nanomolar concentration in ATP-competitive manner (IC50=1-10 nM). | 
            
            
                
            	| PC-35262 | 
                
                	
                		 WY-135 
                       
                  	
                    ALK/ROS1 inhibitor 
                 | 
                
                WY-135 (WY135) is a potent inhibitor of ALK and ROS1 with IC50 of 1.2 and 0.48 nM, respectively. | 
            
            
                
            	| PC-42919 | 
                
                	
                		 Lorlatinib 
                       
                  	
                    ALK/ROS1 inhibitor 
                 | 
                
                Lorlatinib (PF-06463922) is a potent, CNS-penetrant, ATP-competitive inhibitor of ALK/ROS1 with IC50 of 0.07/0.025 nM respectively. | 
            
            
                
            	| PC-25381 | 
                
                	
                		 SAF-189s 
                       
                  	
                    ALK/ROS1 inhibitor 
                 | 
                
                SAF-189s is a potent, highly selective, brain-penetrant, next-generation inhibitor of ALK and ROS1 with IC50 of 1 nM and 0.5 nM, respectively, inhibits ROS1 fusion wild-type and crizotinib-resistant mutants (ROS1 G2032R mutant, IC50=12.4 nM). | 
            
            
                
            	| PC-24947 | 
                
                	
                		 Deulorlatinib 
                       
                  	
                    ALK/ROS1 inhibitor 
                 | 
                
                Deulorlatinib (Lorlatinib-d3) is a deuterated derivative of Lorlatinib (PF-06463922), a potent, CNS-penetrant, ATP-competitive inhibitor of ALK/ROS1. | 
            
            
                
            	| PC-73163 | 
                
                	
                		 ROS1 fusion inhibitor I 
                       
                  	
                    ROS1 fusion inhibitor 
                 | 
                
                ROS1 fusion inhibitor I is a carcinogenic fused kinase (Ros1 fusion kinase) inhibitor. |